Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/1996
04/09/1996US5506214 Use of substituted adenine derivatives for treating multiple sclerosis
04/09/1996US5506213 Adminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel disease
04/06/1996CA2159772A1 5-ht1f agonists for the treatment of migraine
04/06/1996CA2159767A1 5-ht1f mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
04/04/1996WO1996010032A1 Novel estrenes for inducing hypothalamic effects
04/04/1996WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE
04/04/1996WO1996010023A1 1,2,3,4-tetrahydroquinoxalindione derivative
04/04/1996WO1996010018A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
04/04/1996WO1996010012A1 Novel prostaglandin synthase inhibitors
04/04/1996WO1996009830A1 Composition and method for allogeneic mononuclear cell immunotherapy
04/04/1996WO1996009814A1 Spray-dried microparticles as therapeutic vehicles
04/04/1996DE4441483C1 Use of bio-assimilated boron cpds.
04/04/1996CA2201140A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
04/04/1996CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use
04/04/1996CA2199954A1 Spray-dried microparticles as therapeutic vehicles
04/04/1996CA2199044A1 Novel estrenes for inducing hypothalamic effects
04/03/1996EP0704434A1 6-Amino-1,4-dihydropyridines and their use as selective k-channel modulators
04/03/1996EP0703915A1 Heterocyclic chemistry
04/03/1996EP0703914A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist
04/03/1996EP0703908A1 Analgesic dibenzoxazepines and dibenzothiazepines
04/03/1996EP0703901A1 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase
04/03/1996EP0703785A1 Methods for treating muscle diseases and disorders
04/03/1996EP0703781A1 Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
04/03/1996EP0623131B1 Alkyl derivatives of trazodone with cns activity
04/03/1996EP0539503B1 Excitatory amino acid antagonists
04/03/1996EP0426714B1 Acetylenic imidazoles having central nervous system activity
04/02/1996US5504094 Use of bengothiophenls to treat pain due to an excess of neuropeptide y
04/02/1996US5504088 Acetylcholine esterase inhibitors; alzheimer's disease and other diseases caused by a low concentration of choline
04/02/1996US5504085 Treating ischemia, anoxia, hypoglycemia and head, spinal cord trauma
04/02/1996US5503848 Topical dose of sterile, slow-release, lyophilized non-crosslinked hyaluronic acid ester; wound healing agents, ears
04/02/1996US5503845 Produced by intensive moistening of active ingredient with more than 30 weight per cent water in a granulator with maximum energy input
03/1996
03/28/1996WO1996009543A1 In vitro models of cns function and dysfunction
03/28/1996WO1996009408A1 Human galactokinase gene
03/28/1996WO1996009374A1 Human galactokinase gene
03/28/1996WO1996009318A1 Method and pharmaceutical composition for prevention and treatment of brain damage
03/28/1996WO1996009302A1 Bicyclic carboxamides as 5-ht1a antagonists
03/28/1996WO1996009300A1 Novel intermediate for production and process for producing pyridine derivative
03/28/1996WO1996009299A1 Drugs to improved synaptic transmission
03/28/1996WO1996009295A1 Quinoxaline derivatives useful in therapy
03/28/1996WO1996009288A1 Aromatic ethers derived from indols such as 5ht1-like ligands
03/28/1996WO1996009286A1 Isothiourea derivatives as no synthase inhibitors
03/28/1996WO1996009284A1 Novel carbamate compounds and processes for preparing the same
03/28/1996WO1996009283A1 Novel carbamate compounds and processes for preparing the same
03/28/1996WO1996009064A1 Method and pharmaceutical composition for prevention and treatment of brain damage
03/28/1996WO1996009058A1 Remedy and preventive for nervous system disorder
03/28/1996WO1996009047A1 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
03/28/1996WO1996009044A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders
03/28/1996WO1996009042A1 Compositions and methods for the control of smoking
03/28/1996WO1996009038A2 Alteration of activity and/or levels of haem-oxygenase to control inflammation
03/28/1996CA2202526A1 Therapeutic and prophylactic agent for nervous disturbances
03/28/1996CA2200755A1 Compositions and methods for the control of smoking
03/28/1996CA2200722A1 Aromatic ethers derived from indols such as 5ht1-like ligands
03/28/1996CA2200709A1 In vitro models of cns function and dysfunction
03/28/1996CA2200443A1 Bicyclic carboxamides as 5-ht1a antagonists
03/28/1996CA2197554A1 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
03/28/1996CA2176968A1 Novel carbamate compounds and processes for preparing the same
03/27/1996EP0703232A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors
03/27/1996EP0703229A2 Process for the preparation of (R)-3-amino-5-methoxychroman
03/27/1996EP0703218A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
03/27/1996EP0702951A1 Use of a NO-synthetase inhibitor as medicament for reducing alcohol consumption or for preventing excessive alcohol consumption
03/27/1996EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
03/27/1996EP0702681A1 Spiro-substituted azacycles as neurokinin antagonists
03/27/1996EP0702673A1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders
03/27/1996EP0702561A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype
03/27/1996EP0702559A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
03/27/1996EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions
03/27/1996EP0548250B1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
03/27/1996EP0473687B1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester
03/27/1996CN1119189A New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
03/27/1996CN1119100A Preparation of pharmaceutical treating imbalance of memory and recognition with tri-cyclic compound
03/27/1996CN1119099A Method for preparing pharmacologically active CNS composition
03/26/1996US5502203 Certain 6,7-dihydro-3(2-nitrophenyl)-1,2-benzisoxazol-4(5H)-ones as intermediates
03/26/1996US5502079 N-phenylalkyl substituted α-amino carboxamide derivatives and process for their preparation
03/26/1996US5502077 Fatty acid composition
03/26/1996US5502065 Indole derivatives as 5-HT1 -like agonists
03/26/1996US5502064 Cns disorders
03/26/1996US5502059 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them
03/26/1996US5502058 Lidocaine and dextromethorphan or dextrophan
03/26/1996US5502051 Central nervous system, antispasmodic
03/26/1996US5502048 Cns, strokes, hypoglycemic agents and antiischemic agents
03/26/1996US5501861 Carbohydrates
03/23/1996CA2132690A1 Control and modulation of inflammatory response in humans in need of such control and modulation
03/21/1996WO1996008561A1 Method for detection of malfolded protein
03/21/1996WO1996008557A1 Human inositol monophosphatase h1
03/21/1996WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
03/21/1996WO1996008495A1 Fused indole and quinoxaline derivatives, their preparation and use
03/21/1996WO1996008494A1 Indole-2,3-dione-3-oxime derivatives, their preparation and use
03/21/1996WO1996008493A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008492A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008490A1 NOVEL MELATONIN AGONIST β-CARBOLINE DERIVATIVES AND ANALOGS WITH A NAPHTHALENIC STRUCTURE, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS
03/21/1996WO1996008485A1 Quinoxalinedione nmda receptor antagonists
03/21/1996WO1996008241A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane
03/21/1996CA2200056A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2200055A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2199048A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane
03/21/1996CA2198263A1 Method for detection of malfolded protein
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0702013A2 Imidazopyridines
03/20/1996EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists
03/20/1996EP0702010A1 Benzopyranderivatives, process for their preparation and pharmaceutical compositions containing them
1 ... 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 ... 1833